Grifols Sa Adr Stock Performance
| GRFS Stock | USD 8.43 0.08 0.94% |
The company retains a Market Volatility (i.e., Beta) of 0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Grifols SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Grifols SA is expected to be smaller as well. At this point, Grifols SA ADR has a negative expected return of -0.23%. Please make sure to check out Grifols SA's treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Grifols SA ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 529.6 M | |
| Total Cashflows From Investing Activities | 886.7 M |
Grifols SA Relative Risk vs. Return Landscape
If you would invest 982.00 in Grifols SA ADR on August 23, 2025 and sell it today you would lose (139.00) from holding Grifols SA ADR or give up 14.15% of portfolio value over 90 days. Grifols SA ADR is currently does not generate positive expected returns and assumes 1.6828% risk (volatility on return distribution) over the 90 days horizon. In different words, 15% of stocks are less volatile than Grifols, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Grifols SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grifols SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Grifols SA ADR, and traders can use it to determine the average amount a Grifols SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1354
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GRFS |
Estimated Market Risk
| 1.68 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Grifols SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grifols SA by adding Grifols SA to a well-diversified portfolio.
Grifols SA Fundamentals Growth
Grifols Stock prices reflect investors' perceptions of the future prospects and financial health of Grifols SA, and Grifols SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Grifols Stock performance.
| Return On Equity | 0.0589 | ||||
| Return On Asset | 0.0458 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 16.79 B | ||||
| Shares Outstanding | 258.22 M | ||||
| Price To Earning | 14.34 X | ||||
| Price To Book | 0.97 X | ||||
| Price To Sales | 0.93 X | ||||
| Revenue | 7.21 B | ||||
| EBITDA | 1.48 B | ||||
| Cash And Equivalents | 549.09 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 10.09 B | ||||
| Debt To Equity | 1.14 % | ||||
| Book Value Per Share | 7.61 X | ||||
| Cash Flow From Operations | 902.17 M | ||||
| Earnings Per Share | 0.63 X | ||||
| Total Asset | 21.41 B | ||||
| Retained Earnings | 156.92 M | ||||
| Current Asset | 3.09 B | ||||
| Current Liabilities | 1.05 B | ||||
About Grifols SA Performance
Assessing Grifols SA's fundamental ratios provides investors with valuable insights into Grifols SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Grifols SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people.Things to note about Grifols SA ADR performance evaluation
Checking the ongoing alerts about Grifols SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Grifols SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Grifols SA ADR generated a negative expected return over the last 90 days | |
| About 58.0% of the company shares are owned by institutional investors |
- Analyzing Grifols SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Grifols SA's stock is overvalued or undervalued compared to its peers.
- Examining Grifols SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Grifols SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Grifols SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Grifols SA's stock. These opinions can provide insight into Grifols SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Grifols Stock Analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.